Buddy Lyons
Value, long/short equity, contrarian, Growth

Tesaro Offers Excellent Risk-Reward: Market Overreacted To Weaker-Than-Expected Data

Tesaro (NASDAQ:TSRO) tumbled almost 25% on Monday as investors question its ability to differentiate its drug for chemotherapy induced nausea and vomiting (CINV) from existing NK-1 antagonists after missing secondary endpoints in two phase III trials. Rolapitant achieved the primary endpoint of complete response (CR) in the delayed period (24-120 hours) following initiation of chemotherapy in both a highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC). The missed secondary endpoints were overall complete response (0-120 hours) and acute complete response (0-24 hours). We believe the stock price movement is an overreaction and presents a buying opportunity for speculative, patient investors with over 100% potential upside versus 26% potential downside over the next 24 months.

Our investment premise...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
PRO Top long ideas returned 21.7% in 2016**
"As a PRO member, we get uniquely valuable perspective that go beyond our quantiative analysis... We rely on PRO to get beyond the numbers quickly and add much needed perspective. It keeps me ahead of the next big thing. - Mark Choate, Malaga Cove Capital"
Mark Choate, Malaga Cove Capital
"Contributors (writers and commentators), often have a long history in the secuirities they opine on and some are clearly well positioned industry participants with detailed industry views that can help provide color on where the skeletons are buried in a particular secuirity and/or industry."
Jim Roumell, Roumell Asset Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details